Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Clinical Fellow in Cystic Fibrosis
Dyddiad hysbysebu: | 27 Mehefin 2024 |
---|---|
Cyflog: | £55,329.00 bob blwyddyn |
Gwybodaeth ychwanegol am y cyflog: | £55329.00 a year |
Oriau: | Llawn Amser |
Dyddiad cau: | 11 Gorffennaf 2024 |
Lleoliad: | Birmingham, B9 5SS |
Cwmni: | NHS Jobs |
Math o swydd: | Cytundeb |
Cyfeirnod swydd: | C0020-24-1897 |
Crynodeb
Responsible for: 3 clinics per week, ward work as indicated by timetable, and contribution to bronchoscopy lists (if required). Key Working Relationships: Medical, Nursing and Support Staff in clinical Respiratory Medicine. Hours of Work: 40 hours plus on-calls. Job Type: Suitable for CMT level candidates awaiting PACES, SpR level candidates or post-CCT candidates seeking a consultant post in Respiratory Infection/CF. This is a full-time job plan (40-hour week) will be finalised on appointment in keeping with the appointee's needs, comprising ward duties, 3 outpatient clinics/week and negotiable bronchoscopy lists. The Clinical Fellow will be additional to a team of 5 SpRs and 4 non-training grade doctors working at SpR level in clinical respiratory medicine. Although this Job does not have deanery educational approval for clinical experience it will provide training opportunities at the same level as the registrars from the training program. It will suit trainees wishing to develop subspecialty skills in respiratory infection/cystic fibrosis and research as part of out of programme experience (OOPE) or those with a dedicated interest in respiratory medicine that do not have a substantive training post. The duties and responsibilities of the fellow are largely service oriented, but an interest in research can be accommodated and those with a wish to continue in CF may seek other training opportunities, such as visits to other centres. There is one post available from August 2024. The post is appointable for a minimum of 6 months, potentially renewable, dependent on the candidate, and subject to satisfactory progress review through the usual clinical and academic channels.